Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Bausch Health Cos Inc. stock logo
BHC
Bausch Health Cos
$5.73
+1.3%
$5.48
$4.41
$8.69
$2.14B0.422.03 million shs2.00 million shs
Cronos Group Inc. stock logo
CRON
Cronos Group
$2.57
-1.9%
$2.59
$1.84
$3.43
$967.01M0.871.39 million shs1.28 million shs
Knight Therapeutics Inc. stock logo
GUD
Knight Therapeutics
C$8.35
+11.2%
C$6.99
C$5.50
C$8.50
C$818.77M-0.21445194,432 shs355,070 shs
AXS Cannabis ETF stock logo
THCX
AXS Cannabis ETF
$16.60
$16.60
$14.90
$25.40
$141.07M1.7115,071 shsN/A
7 Stocks to Ride The A.I. Megaboom Cover


We are about to experience the greatest A.I. boom in stock market history...

Thanks to a pivotal economic catalyst, specific tech stocks will skyrocket just like they did during the "dot com" boom in the 1990s.

That’s why, we’ve hand-selected 7 tiny tech disruptor stocks positioned to surge.

  1. The first pick is a tiny under-the-radar A.I. stock that's trading for just $3.00. This company already has 98 registered patents for cutting-edge voice and sound recognition technology... And has lined up major partnerships with some of the biggest names in the auto, tech, and music industry... plus many more.
  2. The second pick presents an affordable avenue to bolster EVs and AI development…. Analysts are calling this stock a “buy” right now and predict a high price target of $19.20, substantially more than its current $6 trading price.
  3. Our final and favorite pick is generating a brand-new kind of AI. It's believed this tech will be bigger than the current well-known leader in this industry… Analysts predict this innovative tech is gearing up to create a tidal wave of new wealth, fueling a $15.7 TRILLION market boom.

Right now, we’re staring down the barrel of a true once-in-a-lifetime moment. As an investment opportunity, this kind of breakthrough doesn't come along every day.

And the window to get in on the ground-floor — maximizing profit potential from this expected market surge — is closing quickly...

Simply click the link below to get the names and tickers of the 7 small stocks with potential to make investors very, very happy.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Bausch Health Cos Inc. stock logo
BHC
Bausch Health Cos
+0.18%+1.07%+5.01%-0.88%+18.80%
Cronos Group Inc. stock logo
CRON
Cronos Group
-0.38%+1.55%+1.55%+2.34%+41.62%
Knight Therapeutics Inc. stock logo
GUD
Knight Therapeutics
-0.53%+0.81%-2.34%+28.60%+23.32%
AXS Cannabis ETF stock logo
THCX
AXS Cannabis ETF
0.00%0.00%0.00%0.00%0.00%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Bausch Health Cos Inc. stock logo
BHC
Bausch Health Cos
$5.73
+1.3%
$5.48
$4.41
$8.69
$2.14B0.422.03 million shs2.00 million shs
Cronos Group Inc. stock logo
CRON
Cronos Group
$2.57
-1.9%
$2.59
$1.84
$3.43
$967.01M0.871.39 million shs1.28 million shs
Knight Therapeutics Inc. stock logo
GUD
Knight Therapeutics
C$8.35
+11.2%
C$6.99
C$5.50
C$8.50
C$818.77M-0.21445194,432 shs355,070 shs
AXS Cannabis ETF stock logo
THCX
AXS Cannabis ETF
$16.60
$16.60
$14.90
$25.40
$141.07M1.7115,071 shsN/A
7 Stocks to Ride The A.I. Megaboom Cover


We are about to experience the greatest A.I. boom in stock market history...

Thanks to a pivotal economic catalyst, specific tech stocks will skyrocket just like they did during the "dot com" boom in the 1990s.

That’s why, we’ve hand-selected 7 tiny tech disruptor stocks positioned to surge.

  1. The first pick is a tiny under-the-radar A.I. stock that's trading for just $3.00. This company already has 98 registered patents for cutting-edge voice and sound recognition technology... And has lined up major partnerships with some of the biggest names in the auto, tech, and music industry... plus many more.
  2. The second pick presents an affordable avenue to bolster EVs and AI development…. Analysts are calling this stock a “buy” right now and predict a high price target of $19.20, substantially more than its current $6 trading price.
  3. Our final and favorite pick is generating a brand-new kind of AI. It's believed this tech will be bigger than the current well-known leader in this industry… Analysts predict this innovative tech is gearing up to create a tidal wave of new wealth, fueling a $15.7 TRILLION market boom.

Right now, we’re staring down the barrel of a true once-in-a-lifetime moment. As an investment opportunity, this kind of breakthrough doesn't come along every day.

And the window to get in on the ground-floor — maximizing profit potential from this expected market surge — is closing quickly...

Simply click the link below to get the names and tickers of the 7 small stocks with potential to make investors very, very happy.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Bausch Health Cos Inc. stock logo
BHC
Bausch Health Cos
+0.18%+1.07%+5.01%-0.88%+18.80%
Cronos Group Inc. stock logo
CRON
Cronos Group
-0.38%+1.55%+1.55%+2.34%+41.62%
Knight Therapeutics Inc. stock logo
GUD
Knight Therapeutics
-0.53%+0.81%-2.34%+28.60%+23.32%
AXS Cannabis ETF stock logo
THCX
AXS Cannabis ETF
0.00%0.00%0.00%0.00%0.00%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Bausch Health Cos Inc. stock logo
BHC
Bausch Health Cos
1.80
Reduce$8.0039.74% Upside
Cronos Group Inc. stock logo
CRON
Cronos Group
2.20
Hold$2.30-10.51% Downside
Knight Therapeutics Inc. stock logo
GUD
Knight Therapeutics
3.00
BuyC$6.50-22.16% Downside
AXS Cannabis ETF stock logo
THCX
AXS Cannabis ETF
2.10
Hold$16.60N/A

Current Analyst Ratings Breakdown

Latest GUD, BHC, CRON, and THCX Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/4/2026
Bausch Health Cos Inc. stock logo
BHC
Bausch Health Cos
DowngradeSell (D)Sell (D-)
4/27/2026
Bausch Health Cos Inc. stock logo
BHC
Bausch Health Cos
Lower Price TargetSector Perform$10.00 ➝ $9.00
3/2/2026
Cronos Group Inc. stock logo
CRON
Cronos Group
DowngradeHold (C)Sell (D+)
2/25/2026
Bausch Health Cos Inc. stock logo
BHC
Bausch Health Cos
Lower Price TargetEqual Weight$8.00 ➝ $7.00
2/24/2026
Cronos Group Inc. stock logo
CRON
Cronos Group
Initiated CoverageBuy
2/19/2026
Bausch Health Cos Inc. stock logo
BHC
Bausch Health Cos
DowngradeHold (C)Sell (D+)
(Data available from 5/7/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Bausch Health Cos Inc. stock logo
BHC
Bausch Health Cos
$10.27B0.21$7.44 per share0.77($2.89) per share-1.98
Cronos Group Inc. stock logo
CRON
Cronos Group
$146.59M6.60$0.01 per share209.78$3.00 per share0.86
Knight Therapeutics Inc. stock logo
GUD
Knight Therapeutics
C$450.09M1.82C$2.17 per share3.85C$7.74 per share1.08
AXS Cannabis ETF stock logo
THCX
AXS Cannabis ETF
N/AN/AN/AN/AN/AN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Bausch Health Cos Inc. stock logo
BHC
Bausch Health Cos
$157M-$3.24N/A1.50N/A-11.47%-2,922.77%5.63%N/A
Cronos Group Inc. stock logo
CRON
Cronos Group
-$9.45M-$0.01N/AN/AN/A-6.44%-1.12%-1.07%5/11/2026 (Estimated)
Knight Therapeutics Inc. stock logo
GUD
Knight Therapeutics
-C$30.73M-C$0.05N/AN/A-1.19%-0.70%0.51%N/A
AXS Cannabis ETF stock logo
THCX
AXS Cannabis ETF
N/AN/AN/AN/AN/AN/AN/AN/AN/A

Latest GUD, BHC, CRON, and THCX Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/11/2026Q1 2026
Cronos Group Inc. stock logo
CRON
Cronos Group
$0.01N/AN/AN/A$42.20 millionN/A
5/7/2026Q1 2026
Knight Therapeutics Inc. stock logo
GUD
Knight Therapeutics
N/AC$0.13N/AC$0.13N/AC$147.59 million
4/29/2026Q1 2026
Bausch Health Cos Inc. stock logo
BHC
Bausch Health Cos
$0.81$0.78-$0.03-$3.76$2.37 billion$2.46 billion
3/19/2026Q4 2025
Knight Therapeutics Inc. stock logo
GUD
Knight Therapeutics
N/AC$0.09N/AC$0.09N/AC$133.20 million
2/26/2026Q4 2025
Cronos Group Inc. stock logo
CRON
Cronos Group
$0.01$0.02+$0.01N/A$38.51 million$58.39 million
2/18/2026Q4 2025
Bausch Health Cos Inc. stock logo
BHC
Bausch Health Cos
$1.21$1.08-$0.13-$0.30$2.71 billion$2.78 billion
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Bausch Health Cos Inc. stock logo
BHC
Bausch Health Cos
N/AN/AN/AN/AN/A
Cronos Group Inc. stock logo
CRON
Cronos Group
N/AN/AN/AN/AN/A
Knight Therapeutics Inc. stock logo
GUD
Knight Therapeutics
N/AN/AN/AN/AN/A
AXS Cannabis ETF stock logo
THCX
AXS Cannabis ETF
$0.724.34%N/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Bausch Health Cos Inc. stock logo
BHC
Bausch Health Cos
54.68
1.32
1.08
Cronos Group Inc. stock logo
CRON
Cronos Group
N/A
19.59
18.62
Knight Therapeutics Inc. stock logo
GUD
Knight Therapeutics
10.15
2.39
1.79
AXS Cannabis ETF stock logo
THCX
AXS Cannabis ETF
N/AN/AN/A

Institutional Ownership

CompanyInstitutional Ownership
Bausch Health Cos Inc. stock logo
BHC
Bausch Health Cos
78.65%
Cronos Group Inc. stock logo
CRON
Cronos Group
8.71%
Knight Therapeutics Inc. stock logo
GUD
Knight Therapeutics
23.49%
AXS Cannabis ETF stock logo
THCX
AXS Cannabis ETF
N/A

Insider Ownership

CompanyInsider Ownership
Bausch Health Cos Inc. stock logo
BHC
Bausch Health Cos
20.67%
Cronos Group Inc. stock logo
CRON
Cronos Group
7.80%
Knight Therapeutics Inc. stock logo
GUD
Knight Therapeutics
45.62%
AXS Cannabis ETF stock logo
THCX
AXS Cannabis ETF
N/A
CompanyEmployeesShares OutstandingFree FloatOptionable
Bausch Health Cos Inc. stock logo
BHC
Bausch Health Cos
20,300373.80 million296.54 millionOptionable
Cronos Group Inc. stock logo
CRON
Cronos Group
450376.27 million346.92 millionOptionable
Knight Therapeutics Inc. stock logo
GUD
Knight Therapeutics
72598.06 millionN/ANot Optionable
AXS Cannabis ETF stock logo
THCX
AXS Cannabis ETF
N/A8.50 millionN/ANot Optionable

Recent News About These Companies

Cannabis ETFs: Regulatory Momentum Returns Focus
Aurora Cannabis: Why I Like This Stock
3 Of The Best Cannabis Stocks In The Sector Today

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Bausch Health Cos stock logo

Bausch Health Cos NYSE:BHC

$5.72 +0.08 (+1.33%)
Closing price 03:59 PM Eastern
Extended Trading
$5.73 +0.01 (+0.14%)
As of 04:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Bausch Health Companies Inc. operates as a diversified specialty pharmaceutical and medical device company in the United States and internationally. It develops, manufactures, and markets a range of products primarily in gastroenterology, hepatology, neurology, dermatology, international pharmaceuticals, over-the-counter (OTC) products, aesthetic medical devices, and eye health. The company operates through five segments: Salix, International, Solta Medical, Diversified, and Bausch + Lomb. The Salix segment provides gastroenterology products in the United States. The International segment sells aesthetic medical devices, branded pharmaceuticals, generic pharmaceuticals, and OTC products internationally. The Solta Medical segment engages in the sale of aesthetic medical devices. The Diversified segment offers pharmaceutical products in the areas of neurology and certain other therapeutic classes; generic products; ortho dermatologic; and dentistry products in the United States. The Bausch + Lomb segment offers products in the areas of vision care, surgical, and ophthalmic pharmaceuticals products. The company was formerly known as Valeant Pharmaceuticals International, Inc. and changed its name to Bausch Health Companies Inc. in July 2018. Bausch Health Companies Inc. is headquartered in Laval, Canada.

Cronos Group stock logo

Cronos Group NASDAQ:CRON

$2.57 -0.05 (-1.91%)
Closing price 04:00 PM Eastern
Extended Trading
$2.58 +0.01 (+0.19%)
As of 05:06 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Cronos Group Inc. operates as a cannabinoid company that engages in the cultivation, production and marketing of cannabis products in Canada, Israel, and Germany. It offers dried flower, pre-rolls, oils, vaporizers, edibles, and cannabis tinctures under the Spinach, Lord Jones, and PEACE NATURALS brands. Cronos Group Inc. was founded in 2012 and is based in Toronto, Canada.

Knight Therapeutics stock logo

Knight Therapeutics TSE:GUD

C$8.35 +0.84 (+11.19%)
As of 04:00 PM Eastern

Knight Therapeutics Inc is a specialty and generic drug manufacturing company. The company's principal business activity is focused on developing, acquiring, in-licensing, out-licensing, marketing, and distributing innovative pharmaceutical products, consumer health products, and medical devices in Canada and select international markets. Knight finances other life sciences companies across the globe in order to generate interest income, strengthen relationships in the life sciences industry, and to secure product distribution rights.

AXS Cannabis ETF stock logo

AXS Cannabis ETF NYSEARCA:THCX

$16.60 0.00 (0.00%)
As of 03/1/2024

The Cannabis ETF (THCX) is an exchange-traded fund that is based on the AXS Cannabis index. The fund tracks an index of legal cannabis companies selected and weighted by market capitalization. The fund primarily holds North American companies but may also invest in other countries. THCX was launched on Jul 9, 2019 and is managed by AXS Investments.